Staphylococcus aureus Community Pneumonia Linked to Higher Severity and Distinct Risk Factors

Adults diagnosed with community-acquired Staphylococcus aureus pneumonia experienced more severe disease courses, longer hospital stays, and increased mortality compared to patients with non-staphylococcal community-acquired pneumonia, according to a retrospective comparative study conducted in Chongqing, China. The investigation evaluated clinical features, imaging, laboratory findings, and patient outcomes across 180 adult patients with S. aureus community-acquired pneumonia and an equal comparison cohort of 180 adults with non-S. aureus community-acquired pneumonia.

The comparative analysis identified diabetes mellitus, chronic lung disease, and bronchiectasis as independent risk factors for developing community-acquired S. aureus pneumonia. In subgroup evaluations comparing methicillin-resistant S. aureus (MRSA) with methicillin-susceptible S. aureus (MSSA), researchers observed that a history of prior pneumonia and the presence of dyspnea served as clinical predictors for MRSA infection, a pathogen subset recognized for its association with poor clinical outcomes.

Patients with S. aureus community-acquired pneumonia exhibited greater radiographic abnormalities and elevated markers of systemic inflammation relative to the comparison cohort. These clinical presentations were accompanied by extended hospitalizations, higher rates of intensive care unit admission, and greater overall mortality. Additionally, co-infections were detected in 38.3 percent of the studied cases, consisting predominantly of respiratory viruses and Gram-negative bacteria.

While community-acquired S. aureus pneumonia presented with greater clinical severity than non-S. aureus pneumonia—especially among individuals infected with MRSA—the authors concluded that adverse patient outcomes should not be attributed to pathogen type alone. The researchers emphasized that early risk stratification and the prompt implementation of appropriate empirical antimicrobial therapy represent critical factors for improving clinical outcomes in this high-risk patient population.

Subject of Research: Clinical features and risk factors of community-acquired Staphylococcus aureus pneumonia

Article Title: Risk factors, clinical features, and antimicrobial use in community-acquired Staphylococcus aureus pneumonia in Chongqing, China

Article References: Sheng, Q., Huang, X., You, J., Li, X., & Tong, J. (2026). Risk factors, clinical features, and antimicrobial use in community-acquired Staphylococcus aureus pneumonia in Chongqing, China. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-026-04949-x

Image Credits: AI Generated

DOI: 10.1186/s12890-026-04949-x

Keywords: Staphylococcus aureus, community-acquired pneumonia, MRSA, bacterial co-infections, intensive care unit, pulmonary medicine, risk factors, antimicrobial therapy, Risk, factors, clinical, features